Novel Therapies for Essential Tremor
NCT00018564 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2009-01-21
Summary
This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.
Conditions
Interventions
- DRUG
-
treatments for essential tremor
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Fredricka Martin, Ph.D.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Completion
- 2003-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
NCT00524056 ·Status: COMPLETED ·Phase: PHASE2
-
Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor
NCT03465761 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 RCT Study of CX-8998 for Essential Tremor
NCT03101241 ·Status: COMPLETED ·Phase: PHASE2
-
Upper Limb Tremor Reduction in Essential Tremor Patients
NCT06343285 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT04305275 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate CAD-1883 in Essential Tremor
NCT03688685 ·Status: COMPLETED ·Phase: PHASE2
-
1-Octanol to Treat Essential Tremor
NCT00001986 ·Status: COMPLETED ·Phase: PHASE1
-
Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor
NCT00848172 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor
NCT00598078 ·Status: COMPLETED ·Phase: PHASE2
-
Octanoic Acid for Essential Tremor
NCT01468948 ·Status: COMPLETED ·Phase: PHASE1
-
Acamprosate and Methazolamide for Essential Tremor
NCT06312800 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
NCT03214588 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen
NCT04825119 ·Status: UNKNOWN
-
GyroGlove Use in Essential Tremor Patients
NCT05958030 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Pilot Study of the Cala ONE Device for Essential Tremor
NCT03152136 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
NCT05573698 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor
NCT05021991 ·Status: COMPLETED ·Phase: PHASE2
-
4-Aminopyridine in Episodic Ataxia Type 2
NCT01543750 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
NCT04102501 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT05285540 ·Status: COMPLETED ·Phase: PHASE1
-
Cala ONE Device for Essential Tremor
NCT02629614 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA)
NCT01839656 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Cannabis for Essential Tremor
NCT03805750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Oral Treatment MTR-601 in Cervical Dystonia
NCT06830642 ·Status: SUSPENDED ·Phase: PHASE2